Edwards Lifesciences' Long-term Business Outlook Appears Achievable, RBC Says [Yahoo! Finance]
Edwards Lifesciences (NYSE:EW) was given a new $92.00 price target on by analysts at UBS Group AG.
Edwards Lifesciences (NYSE:EW) had its price target raised by analysts at Royal Bank Of Canada from $95.00 to $100.00. They now have an "outperform" rating on the stock.
Edwards Lifesciences (NYSE:EW) was given a new $100.00 price target on by analysts at Stifel Nicolaus.
Edwards Lifesciences (NYSE:EW) was given a new $92.00 price target on by analysts at Truist Financial Corporation.